Back to CGEM

GOLDMAN SACHS GROUP INC → CGEM

GOLDMAN SACHS GROUP INC CGEM Position History

Cullinan Therapeutics, Inc. • Healthcare

Quarters held
14
Latest value
$3.4M
Q3 2026
Peak value
$17.4M
First seen
Q2 2025

Dollar value over time

Show data table
PeriodPosition value
Q2 2025$3.9M
Q2 2025$1.4M
Q3 2025$3.8M
Q3 2025$2.1M
Q4 2025$3.3M
Q4 2025$4.2M
Q4 2025$4.2M
Q4 2025$3.3M
Q1 2026$6M
Q1 2026$493K
Q2 2026$17.4M
Q2 2026$810K
Q3 2026$11.8M
Q3 2026$3.4M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$3.4M219.3K——
Q3 2026$11.8M769.6K——
Q2 2026$810K44.5K——
Q2 2026$17.4M957.1K——
Q1 2026$493K34.7K——
Q1 2026$6M420.7K——
Q4 2025$3.3M319.1K——
Q4 2025$4.2M402.7K——
Q4 2025$4.2M402.7K——
Q4 2025$3.3M319.1K——
Q3 2025$2.1M348.3K——
Q3 2025$3.8M635.6K——
Q2 2025$1.4M183.1K——
Q2 2025$3.9M519.1K——

Other funds holding CGEM

Other GOLDMAN SACHS GROUP INC positions

NVDA

NVIDIA CORPORATION

$37B
AAPL

APPLE INC

$31.7B
NVDA

NVIDIA CORPORATION

$31.3B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.3B
AAPL

APPLE INC

$26.9B
NVDA

NVIDIA CORPORATION

$26.5B